Apollo Hospitals Enterprise share price ends at ₹8,768.50; September 17 gain at 0.83%

Key Takeaways

• Apollo Hospitals Enterprise closed at ₹8,768.50 after gaining ₹72 or 0.83%, finishing only ₹30.50 below the day's ₹8,799 high. 
• The closing price was above its 50-day, 100-day and 200-day DMAs, with the widest gap against the ₹8,159.80 200-day measure. 
• Six-month and one-year returns stood at 17.07% and 11.67%, while the one-month reading remained negative at 1.70%. 

Apollo Hospitals Enterprise share price ended September 17 at ₹8,768.50, up ₹72 or 0.83% on the 5paisa price page. The share had closed the previous session at ₹8,697 and opened at ₹8,707. It then travelled through a ₹112 band, touching ₹8,687 at the low and ₹8,799 at the high. Only ₹30.50 separated the final price from the session high. 

The stock's position against its recent moving averages was quite different from its one-month return. Apollo Hospitals closed ₹26.90 above its 50-day DMA of ₹8,741.60. The 100-day DMA was lower at ₹8,523.70, leaving a ₹244.80 gap to the closing price, while the 200-day DMA of ₹8,159.80 was ₹608.70 below the September 17 finish. 

Trading volume came in at 249,871 shares. Market capitalisation was ₹1,26,078 crore. The stock's 52-week range extended from ₹6,697 to ₹9,050, placing the latest close ₹281.50 below the yearly peak. The distance above the 52-week low was much larger at ₹2,071.50. 

Recent return figures were uneven across time frames. Apollo Hospitals recorded a one-month return of -1.70%, but the three-month reading was positive at 4.51%. Six-month performance rose to 17.07%, while the one-year return was 11.67%. The six-month figure was therefore stronger than both the three-month and one-year readings shown on the page. 

Price action during September 17 also differed from the modest one-month decline. The stock started ₹10 above the previous close, slipped below that level intraday when it reached ₹8,687, and later advanced to ₹8,799. It retained most of that recovery into the end of the session. With the closing price above all three cited DMAs and less than ₹300 away from the 52-week high, the session's key figures were concentrated near the upper end of the stock's annual trading range.